{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:09:39Z","timestamp":1767982179905,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00702-018-1950-9","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T06:20:33Z","timestamp":1540794033000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood\u2013brain barrier breakdown in patients with paraneoplastic neurological syndromes"],"prefix":"10.1007","volume":"126","author":[{"given":"Slawomir","family":"Michalak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-1637","authenticated-orcid":false,"given":"Alicja","family":"Kalinowska-Lyszczarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Rybacka-Mossakowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikolaj","family":"Zaborowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Kozubski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"1950_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/1097-0142(19890201)63:3<496::AID-CNCR2820630318>3.0.CO;2-K","volume":"63","author":"K Ambe","year":"1989","unstructured":"Ambe K, Mori M, Enjoji M (1989) S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer 63:496\u2013503","journal-title":"Cancer"},{"issue":"6","key":"1950_CR2","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.0808698106","volume":"106","author":"AT Argaw","year":"2009","unstructured":"Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR (2009) VEGF-mediated disruption of endothelial CLN-5 promotes blood\u2013brain barrier breakdown. Proc Natl Acad Sci USA 106(6):1977\u20131982","journal-title":"Proc Natl Acad Sci USA"},{"key":"1950_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1053\/ctrv.2000.0194","volume":"26","author":"J Bart","year":"2000","unstructured":"Bart J, Groen HJ, Hendrikse NH, van der Graaf WT, Vaalburg W, de Vries EG (2000) The blood\u2013brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 26:449\u2013462","journal-title":"Cancer Treat Rev"},{"key":"1950_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R","volume":"45","author":"B Benyahia","year":"1999","unstructured":"Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY (1999) Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 45:162\u2013167","journal-title":"Ann Neurol"},{"key":"1950_CR5","first-page":"11","volume":"1586","author":"M Beppu","year":"2002","unstructured":"Beppu M, Ikebe T, Shirasuna K (2002) The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-UB-mediated protease production by oral cancer. BBA 1586:11\u201322","journal-title":"BBA"},{"key":"1950_CR6","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.4049\/jimmunol.178.3.1505","volume":"178","author":"C Bouzin","year":"2007","unstructured":"Bouzin C, Brouet A, De Vriese J, DeWever J, Feron O (2007) Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy. J Immunol 178:1505\u20131511","journal-title":"J Immunol"},{"key":"1950_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0046-8177(95)90119-1","volume":"26","author":"LF Brown","year":"1995","unstructured":"Brown LF, Berse B, Jackman RW (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26:86\u201391","journal-title":"Hum Pathol"},{"key":"1950_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/1097-0142(19900315)65:6<1386::AID-CNCR2820650623>3.0.CO;2-9","volume":"65","author":"OC Burghuber","year":"1990","unstructured":"Burghuber OC, Worofka B, Schernthaner G, Vetter N, Neumann M, Dudczak R, Kuzmits R (1990) Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 65:1386\u20131390","journal-title":"Cancer"},{"key":"1950_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jlb.64.2.235","volume":"64","author":"B Canque","year":"1998","unstructured":"Canque B, Camus S, Yagello M, Gluckman JC (1998) IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD341 cell-derived CD1a1. J Leukoc Biol 64:235\u2013244","journal-title":"J Leukoc Biol"},{"key":"1950_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0165-5728(96)00179-8","volume":"72","author":"S Chandler","year":"1997","unstructured":"Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE, Gearing AJ (1997) Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 72:155\u2013161","journal-title":"J Neuroimmunol"},{"key":"1950_CR11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0021-9258(18)48525-0","volume":"267","author":"ML Corcoran","year":"1992","unstructured":"Corcoran ML, Stetler-Stevenson WG, Brown PD, Wahl LM (1992) Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase\/gelatinase production by human monocytes. J Biol Chem 267:515\u2013519","journal-title":"J Biol Chem"},{"key":"1950_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000217786","volume":"13","author":"M D\u2019Alessandro","year":"1992","unstructured":"D\u2019Alessandro M, Mariani P, Lomanto D, Carlei F, Lezoche E, Speranza V (1992) Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors. Tumour Biol 13:352\u2013357","journal-title":"Tumour Biol"},{"key":"1950_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s00262-004-0548-2","volume":"53","author":"AR Dadabayev","year":"2004","unstructured":"Dadabayev AR, Sandel MH, Menon AG, Morreau H, Melief CJ, Offringa R, van der Burg SH, Janssen-van Rhijn C, Ensink NG, Tollenaar RA, van de Velde CJ, Kuppen PJ (2004) Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother 53:978\u2013986","journal-title":"Cancer Immunol Immunother"},{"issue":"1\u20132","key":"1950_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2013.02.006","volume":"258","author":"AH Jongste de","year":"2013","unstructured":"de Jongste AH, de Graaf MT, van den Broek PD, Kraan J, Smitt PA, Gratama JW (2013) Elevated numbers of regulatory T cells, central memory T cells and class-switched B cells in cerebrospinal fluid of patients with anti-Hu antibody associated paraneoplastic neurological syndromes. J Neuroimmunol 258(1\u20132):85\u201390","journal-title":"J Neuroimmunol"},{"key":"1950_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1053\/hupa.2001.26455","volume":"32","author":"A Eisenthal","year":"2001","unstructured":"Eisenthal A, Polyvkin N, Bramante-Schreiber L, Misonznik F, Hassner A, Lifschitz-Mercer B (2001) Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Hum Pathol 32:803\u2013807","journal-title":"Hum Pathol"},{"key":"1950_CR16","first-page":"357","volume":"72","author":"C Ferrari","year":"1988","unstructured":"Ferrari C, Sansoni P, Rowden G, Manara GC, Torresani C, De Panfilis G (1988) One half of the CD11b+ human peripheral blood T lymphocytes coexpresses the S-100 protein. Clin Exp Immunol 72:357\u2013361","journal-title":"Clin Exp Immunol"},{"key":"1950_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","volume":"57","author":"J Folkman","year":"2006","unstructured":"Folkman J (2006) Angiogenesis. Ann Rev Med 57:1\u201318","journal-title":"Ann Rev Med"},{"key":"1950_CR18","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nm1096-1096","volume":"2","author":"DI Gabrilovich","year":"1996","unstructured":"Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096\u20131103","journal-title":"Nat Med"},{"key":"1950_CR19","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","volume":"92","author":"D Gabrilovich","year":"1998","unstructured":"Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone DP (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92:4150\u20134166","journal-title":"Blood"},{"key":"1950_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/archotol.124.6.641","volume":"124","author":"SA Goldman","year":"1998","unstructured":"Goldman SA, Baker E, Weyant RJ, Clarke MR, Myers JN, Lotze MT (1998) Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 124:641\u2013646","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1950_CR21","first-page":"111","volume":"74","author":"DE Gomez","year":"1997","unstructured":"Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74:111\u2013122","journal-title":"Eur J Cell Biol"},{"key":"1950_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.0300-9475.2005.01524.x","volume":"61","author":"A Gratchev","year":"2005","unstructured":"Gratchev A, Kzhyshkowska J, Utikal J, Goerdt S (2005) Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand J Immunol 61:10\u201317","journal-title":"Scand J Immunol"},{"key":"1950_CR23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135\u20131140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1950_CR24","first-page":"113","volume-title":"The brain and cardiac surgery","author":"HP Grocott","year":"2001","unstructured":"Grocott HP, Laskowitz DT, Newman MF (2001) Markers of cerebral injury. In: Newman SP, Harrison MJG (eds) The brain and cardiac surgery. Harwood Academic Publishers, Amsterdam, pp\u00a0113\u2013142"},{"issue":"6","key":"1950_CR25","doi-asserted-by":"publisher","first-page":"9174","DOI":"10.18632\/oncotarget.13942","volume":"8","author":"M Guyot","year":"2017","unstructured":"Guyot M, Hilmi C, Ambrosetti D, Merlano M, Lo Nigro C, Durivault J, Gr\u00e9pin R, Pag\u00e8s G (2017) Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies. Oncotarget 8(6):9174\u20139188","journal-title":"Oncotarget"},{"key":"1950_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1042\/bj2960803","volume":"296","author":"R Hanemaaijer","year":"1993","unstructured":"Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW (1993) Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 296:803\u2013809","journal-title":"Biochem J"},{"key":"1950_CR27","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1073\/pnas.86.10.3803","volume":"86","author":"PH Hart","year":"1989","unstructured":"Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA (1989) Potential anti-inflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor a, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86:3803\u20133807","journal-title":"Proc Natl Acad Sci USA"},{"key":"1950_CR28","doi-asserted-by":"publisher","first-page":"L1147","DOI":"10.1152\/ajplung.00294.2006","volume":"292","author":"H Huang","year":"2007","unstructured":"Huang H, Lavoie-Lamoureux A, Moran K, Lavoie JP (2007) IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 292:L1147\u2013L1154","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1950_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ijc.10915","volume":"104","author":"M Iwamoto","year":"2003","unstructured":"Iwamoto M, Shinohara H, Miyamoto A, Okuzawa M, Mabuchi H, Nohara T, Gon G, Toyoda M, Tanigawa N (2003) Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 104:92\u201397","journal-title":"Int J Cancer"},{"key":"1950_CR30","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.4049\/jimmunol.158.5.2327","volume":"158","author":"RN Johnatty","year":"1997","unstructured":"Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, Rees RC (1997) Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 158:2327\u20132333","journal-title":"J Immunol"},{"key":"1950_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1053\/jcan.2000.18444","volume":"14","author":"H J\u00f6nsson","year":"2000","unstructured":"J\u00f6nsson H, Johnsson P, H\u00f6glund P, Alling C, Blomqvist S (2000) Elimination of S100B andrenal function after cardiac surgery. J Cardiothorac Vasc Anesth 14:698\u2013701","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1950_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0006-8993(02)02586-6","volume":"940","author":"M Kapural","year":"2002","unstructured":"Kapural M, Krizanac-Bengez LJ, Barnett G, Perl J, Masaryk T, Apollo D, Rasmussena P, Mayberga MR, Janigro D (2002) Serum S-100b as a possible marker of blood\u2013brain barrier disruption. Brain Res 940:102\u2013104","journal-title":"Brain Res"},{"key":"1950_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7","volume":"85","author":"A Kraft","year":"1999","unstructured":"Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marm\u00e9 D, Gastl G (1999) Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85:178\u2013187","journal-title":"Cancer"},{"key":"1950_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<309::AID-IJC19>3.0.CO;2-3","volume":"84","author":"L Lespagnard","year":"1999","unstructured":"Lespagnard L, Gancberg D, Rouas G, Leclercq G, de Saint-Aubain Somerhausen N, Di Leo A, Piccart M, Verhest A, Larsimont D (1999) Tumor infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer 84:309\u2013314","journal-title":"Int J Cancer"},{"key":"1950_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s004010000180","volume":"100","author":"S Liebner","year":"2000","unstructured":"Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, Wolburg H (2000) Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol (Berl) 100:323\u2013331","journal-title":"Acta Neuropathol (Berl)"},{"key":"1950_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1023\/A:1012493808790","volume":"6","author":"F Mannello","year":"2001","unstructured":"Mannello F, Gazzanelli G (2001) Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6:479\u2013482","journal-title":"Apoptosis"},{"key":"1950_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.ne.10.030187.001413","volume":"10","author":"PJ Marangos","year":"1987","unstructured":"Marangos PJ, Schmechel DE (1987) Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Ann Rev Neurosci 10:269\u2013295","journal-title":"Ann Rev Neurosci"},{"key":"1950_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1471-4159.1979.tb11735.x","volume":"33","author":"PJ Marangos","year":"1979","unstructured":"Marangos PJ, Schmechel D, Parma AM, Clark RL, Goodwin FK (1979) Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J Neurochem 33:319\u2013329","journal-title":"J Neurochem"},{"key":"1950_CR39","doi-asserted-by":"publisher","first-page":"C1148","DOI":"10.1152\/ajpcell.1999.276.5.C1148","volume":"276","author":"WG Mayhan","year":"1999","unstructured":"Mayhan WG (1999) VEGF increases permeability of the blood\u2013brain barrier via a nitric oxide synthase\/cGMP-dependent pathway. Am J Physiol 276:C1148\u2013C1153","journal-title":"Am J Physiol"},{"key":"1950_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1096\/fj.00-0247com","volume":"15","author":"D Mechtcheriakova","year":"2001","unstructured":"Mechtcheriakova D, Schabbauer G, Lucerna M, Clauss M, De Martin R, Binder BR, Hofer E (2001) Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J 15:230\u2013242","journal-title":"FASEB J"},{"key":"1950_CR41","first-page":"3096","volume":"61","author":"CH Menetrier-Caux","year":"2001","unstructured":"Menetrier-Caux CH, Thomachot MC, Alberti L, Montmain G, Blay JY (2001) IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. Cancer Res 61:3096\u20133104","journal-title":"Cancer Res"},{"key":"1950_CR42","first-page":"93","volume":"48","author":"S Michalak","year":"2010","unstructured":"Michalak S, Wender M, Michalowska-Wender G, Kozubski W (2010) Blood\u2013brain barrier breakdown and cerebellar degeneration in the course of experimental neoplastic disease. Are circulating cytokine-induced neutrophil chemoattractant-1 (CINC-1) and -2alpha(CINC-2alpha) the involved mediators? Folia Neuropathol 48:93\u2013103","journal-title":"Folia Neuropathol"},{"key":"1950_CR43","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/annonc\/mdi208","volume":"16","author":"R Midgley","year":"2005","unstructured":"Midgley R, Kerr D (2005) Bevacizumab\u2014current status and future directions. Ann Oncol 16:999\u20131004","journal-title":"Ann Oncol"},{"key":"1950_CR44","first-page":"89","volume":"1","author":"PP Moln\u00e1r","year":"1999","unstructured":"Moln\u00e1r PP, O\u2019Neill BP, Scheithauer BW, Groothuis DR (1999) The blood\u2013brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death. NeuroOncology 1:89\u2013100","journal-title":"NeuroOncology"},{"key":"1950_CR45","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.4049\/jimmunol.172.7.4618","volume":"172","author":"F Mor","year":"2004","unstructured":"Mor F, Quintana FJ, Cohen IR (2004) Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172:4618\u20134623","journal-title":"J Immunol"},{"key":"1950_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1385\/IR:23:2-3:263","volume":"23","author":"JE Ohm","year":"2001","unstructured":"Ohm JE, Carbone DP (2001) VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res 23:263\u2013272","journal-title":"Immunol Res"},{"key":"1950_CR47","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1182\/blood-2002-07-1956","volume":"101","author":"JE Ohm","year":"2003","unstructured":"Ohm JE, Gabrilovich DI, Sempowski GD, Kisseleva E, Parman KS, Nadaf S, Carbone DP (2003) VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 101:4878\u20134886","journal-title":"Blood"},{"key":"1950_CR48","first-page":"1411","volume":"2","author":"Y Ohta","year":"1996","unstructured":"Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, Watanabe Y, Sasaki T (1996) Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res 2:1411\u20131416","journal-title":"Clin Cancer Res"},{"key":"1950_CR49","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1468::AID-CNCR6>3.0.CO;2-5","volume":"82","author":"T Okuyama","year":"1998","unstructured":"Okuyama T, Maehara Y, Kakeji Y, Tsuijitani S, Korenaga D, Sugimachi K (1998) Interrelation between tumor-associated cell surface glycoprotein and host immune response in gastric carcinoma patients. Cancer 82:1468\u20131475","journal-title":"Cancer"},{"key":"1950_CR50","first-page":"276","volume":"54","author":"TA Olson","year":"1994","unstructured":"Olson TA, Mohanraj D, Carson LF, Ramakrishnan S (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54:276\u2013280","journal-title":"Cancer Res"},{"key":"1950_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jnr.20483","volume":"81","author":"KW Park","year":"2005","unstructured":"Park KW, Lee DY, Joe EH, Kim SU, Jin BK (2005) Neuroprotective role of microglia expressing interleukin-4. J Neurosci Res 81:397\u2013402","journal-title":"J Neurosci Res"},{"key":"1950_CR52","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.1523\/JNEUROSCI.1922-07.2007","volume":"27","author":"ED Ponomarev","year":"2007","unstructured":"Ponomarev ED, Maresz K, Tan Y, Dittel BN (2007) CNS-derived interleukin-4 Is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27:10714\u201310721","journal-title":"J Neurosci"},{"key":"1950_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/A:1013104423154","volume":"20","author":"A Regina","year":"2001","unstructured":"Regina A, Demeule M, Laplante A, Jodoin J, Dagenais C, Berthelet F, Moghrabi A, B\u00e9liveau R (2001) Multidrug resistance in brain tumors: roles of the blood\u2013brain barrier. Cancer Metastasis Rev 20:13\u201325","journal-title":"Cancer Metastasis Rev"},{"key":"1950_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/glia.10108","volume":"39","author":"GA Rosenberg","year":"2002","unstructured":"Rosenberg GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39:279\u2013291","journal-title":"Glia"},{"key":"1950_CR55","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1158\/1078-0432.CCR-04-1448","volume":"11","author":"MH Sandel","year":"2005","unstructured":"Sandel MH, Dadabayev AR, Menon AG, Morreau H, Melief CJM, Offringa R, van der Burg SH, Janssen-van Rhijn CM, Geeske Ensink N, Tollenaar RAEM, van deVelde CJH, Kuppen PJK (2005) Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res 11:2576\u20132582","journal-title":"Clin Cancer Res"},{"key":"1950_CR56","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1046\/j.1365-2133.1998.02119.x","volume":"138","author":"ES Schultz","year":"1998","unstructured":"Schultz ES, Diepgen TL, Von Den Driesch P (1998) Clinical and prognostic relevance of serum S-100\u03b2 protein in malignant melanoma. Br J Dermatol 138:426\u2013430","journal-title":"Br J Dermatol"},{"key":"1950_CR57","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF00665960","volume":"12","author":"DR Senger","year":"1993","unstructured":"Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK et al (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12:303\u2013324","journal-title":"Cancer Metastasis Rev"},{"key":"1950_CR58","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/BF00215531","volume":"249","author":"JD Shearman","year":"1987","unstructured":"Shearman JD, Franks AJ (1987) S-100 protein in Schwann cells of the developing human peripheral nerve. An immunohistochemical study. Cell Tissue Res 249:459\u2013463","journal-title":"Cell Tissue Res"},{"key":"1950_CR59","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/BF00691283","volume":"78","author":"S Shibata","year":"1989","unstructured":"Shibata S (1989) Ultrastructure of capillary walls in human brain tumors. Acta Neuropathol Berl 78:561\u2013571","journal-title":"Acta Neuropathol Berl"},{"key":"1950_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010275","author":"JW Shim","year":"2018","unstructured":"Shim JW, Madsen JR (2018) VEGF signaling in neurological disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19010275","journal-title":"Int J Mol Sci"},{"key":"1950_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2199-8-12","volume":"8","author":"D Stewart","year":"2007","unstructured":"Stewart D, Javadi M, Chambers M, Gunsolly Ch, Gorski G, Borghaei RC (2007) Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPAR\u03b3 activation in human gingival fibroblasts. BMC Mol Biol 8:1\u201312","journal-title":"BMC Mol Biol"},{"key":"1950_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ajcp\/83.1.69","volume":"83","author":"K Takahashi","year":"1985","unstructured":"Takahashi K, Isobe T, Ohtsuki Y, Sonobe H, Yamaguchi H, Akagi T (1985) S-100 positive human T-lymphocyte. Am J Clin Pathol 83:69\u201372","journal-title":"Am J Clin Pathol"},{"key":"1950_CR63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood.V70.1.214.214","volume":"70","author":"K Takahashi","year":"1987","unstructured":"Takahashi K, Yoshino T, Hayashi K, Sonobe H, Ohtsuki Y (1987) S-100 beta positive human t lymphocytes: their characteristics and behavior under normal and pathologic conditions. Blood 70:214\u2013220","journal-title":"Blood"},{"key":"1950_CR64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1044-7431(02)00024-6","volume":"22","author":"HK Tan","year":"2003","unstructured":"Tan HK, Heywood D, Ralph GS, Bienemann A, Baker AH, Uney JB (2003) Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci 22:98\u2013106","journal-title":"Mol Cell Neurosci"},{"key":"1950_CR65","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0022-510X(99)00029-5","volume":"163","author":"K Tanaka","year":"1999","unstructured":"Tanaka K, Tanaka M, Inuzuka T, Nakano R, Tsuji S (1999) Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci 163:159\u2013162","journal-title":"J Neurol Sci"},{"key":"1950_CR66","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1182\/blood-2004-10-4054","volume":"105","author":"KJ Till","year":"2005","unstructured":"Till KJ, Spiller DG, Harris RJ, Chen H, Zuzel M, Cawley JC (2005) CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4-beta1 integrin for chemokine-induced motility on and through endothelium. Blood 105:4813\u20134819","journal-title":"Blood"},{"key":"1950_CR67","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/WNL.51.4.1146","volume":"51","author":"R Voltz","year":"1998","unstructured":"Voltz R, Dalmau J, Posner JB, Rosenfeld MR (1998) T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 51:1146\u20131150","journal-title":"Neurology"},{"key":"1950_CR68","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ajcp\/102.4.478","volume":"102","author":"A Zarate-Osorno","year":"1994","unstructured":"Zarate-Osorno A, Raffeld M, Berman EL, Ferguson MM, Andrade R, Jaffe ES (1994) S-100 positive T-cell lymphoproliferative disorder. A case report and review of the literature. Am J Clin Pathol 102:478\u2013482","journal-title":"Am J Clin Pathol"},{"key":"1950_CR69","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/1097-0142(19860315)57:6<1230::AID-CNCR2820570628>3.0.CO;2-#","volume":"57","author":"PM Zeltzer","year":"1986","unstructured":"Zeltzer PM, Marangos PJ, Evans AE, Schneider SL (1986) Serum neuron-specific enolase in children with neuroblastoma: relationship to stage and disease course. Cancer 57:1230\u20131234","journal-title":"Cancer"},{"key":"1950_CR70","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0361-9230(95)00040-2","volume":"37","author":"DB Zimmer","year":"1995","unstructured":"Zimmer DB, Cornwall EH, Landar A, Song W (1995) The S100 protein family: history, function and expression. Brain Res Bull 37:417\u2013429","journal-title":"Brain Res Bull"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1950-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1950-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1950-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:17:02Z","timestamp":1694006222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1950-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1950"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1950-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study protocol was approved by the Internal Review Board at the Poznan University of Medical Sciences. Written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The authors have declared that no competing interests exist.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}